How Are Tyrosine Kinase Inhibitors Shaping Colorectal Cancer Treatment?
Colorectal cancer remains a global health concern, demanding novel treatment approaches beyond traditional surgery and chemotherapy. Tyrosine kinase inhibitors (TKIs) like osimertinib and fruquintinib are at the forefront, offering targeted strategies to combat cancer progression and improve patient outcomes. Combining TKIs with other therapies highlights the potential for enhanced survival rates. Delve into the transformative […]
3 minute read